THE MEDICAL TREATMENT OF SCHOOL CHILDREN

Abstract

The MAPKKK dual leucine zipper-containing kinase (DLK, Wallenda in <i>Drosophila</i>) is an evolutionarily conserved component of the axonal injury response pathway. After nerve injury, DLK promotes degeneration of distal axons and regeneration of proximal axons. This dual role in coordinating degeneration and regeneration suggests that DLK may be a sensor of axon injury, and so understanding how DLK is activated is important. Two mechanisms are known to activate DLK. First, increasing the levels of DLK via overexpression or loss of the PHR ubiquitin ligases that target DLK activate DLK signaling. Second, in <i>Caenorhabditis elegans</i>, a calcium-dependent mechanism, can activate DLK. Here we describe a new mechanism that activates DLK in <i>Drosophila</i>: loss of the spectraplakin <i>short stop</i> (<i>shot</i>). In a genetic screen for mutants with defective neuromuscular junction development, we identify a hypomorphic allele of <i>shot</i> that displays synaptic terminal overgrowth and a precocious regenerative response to nerve injury. We demonstrate that both phenotypes are the result of overactivation of the DLK signaling pathway. We further show that, unlike mutations in the PHR ligase Highwire, loss of function of <i>shot</i> activates DLK without a concomitant increase in the levels of DLK. As a spectraplakin, Shot binds to both actin and microtubules and promotes cytoskeletal stability. The DLK pathway is also activated by downregulation of the TCP1 chaperonin complex, whose normal function is to promote cytoskeletal stability. These findings support the model that DLK is activated by cytoskeletal instability, which is a shared feature of both spectraplakin mutants and injured axons.